BIOMAT Database Logo BIOMAT Database Logo

Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial. 1989

M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
Anxiety Disorders Clinic, New York State Psychiatric Institute, NY 10032.

The selective serotonin reuptake blocker fluoxetine was administered to 49 patients with obsessive-compulsive disorder in a 12-week open clinical trial. A minimum adequate trial of at least 8 weeks of treatment was completed by 39 patients. Response rates were 62% (24/39) of adequately treated patients and 49% (24/49) of the whole sample. These uncontrolled findings suggest that fluoxetine is of significant benefit for a substantial proportion of obsessive-compulsive disorder patients. However, controlled trials comparing fluoxetine with placebo and other active agents are needed to confirm this, as are studies aimed to delineate fluoxetine's full dose range, optimal length of treatment and relapse rate following discontinuation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009771 Obsessive-Compulsive Disorder An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension. Anankastic Personality,Neurosis, Obsessive-Compulsive,Anankastic Personalities,Disorder, Obsessive-Compulsive,Disorders, Obsessive-Compulsive,Neuroses, Obsessive-Compulsive,Neurosis, Obsessive Compulsive,Obsessive Compulsive Disorder,Obsessive-Compulsive Disorders,Obsessive-Compulsive Neuroses,Obsessive-Compulsive Neurosis,Personalities, Anankastic,Personality, Anankastic
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
April 1986, Journal of clinical psychopharmacology,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
Open trial of fluoxetine in obsessive-compulsive disorder.
July 1989, The American journal of psychiatry,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial.
April 1998, Journal of the American Academy of Child and Adolescent Psychiatry,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
Fluoxetine treatment of obsessive compulsive disorder.
November 1989, The Journal of clinical psychiatry,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
Fluoxetine treatment of obsessive-compulsive disorder.
December 1991, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
Fluoxetine treatment of obsessive-compulsive disorder.
August 1985, Journal of clinical psychopharmacology,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.
August 2003, Human psychopharmacology,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
An open trial of buspirone in obsessive-compulsive disorder.
October 1988, The American journal of psychiatry,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
An open trial and discontinuation study of fluoxetine in children and adolescents with obsessive-compulsive disorder.
January 2001, The Turkish journal of pediatrics,
M R Liebowitz, and E Hollander, and F Schneier, and R Campeas, and J Hatterer, and L Papp, and J Fairbanks, and D Sandberg, and S Davies, and M Stein
An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome.
June 1991, Neurology,
Copied contents to your clipboard!